These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2532141)

  • 21. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
    Rickert RC
    Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic expression of B lymphocytes. III. Marginal zone B cells in the spleen are characterized by the expression of Tac and alkaline phosphatase.
    Hsu SM
    J Immunol; 1985 Jul; 135(1):123-30. PubMed ID: 2987343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
    Luxembourg AT; Cooper NR
    J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human peripheral blood B lymphocyte subpopulations: functional and phenotypic analysis of surface IgD positive and negative subsets.
    Jelinek DF; Splawski JB; Lipsky PE
    J Immunol; 1986 Jan; 136(1):83-92. PubMed ID: 3484392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help.
    Lederman S; Yellin MJ; Inghirami G; Lee JJ; Knowles DM; Chess L
    J Immunol; 1992 Dec; 149(12):3817-26. PubMed ID: 1281189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues. Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies.
    Sánchez-Mateos P; Cebrián M; Acevedo A; López-Botet M; De Landázuri MO; Sánchez-Madrid F
    Immunology; 1989 Sep; 68(1):72-9. PubMed ID: 2807372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the CD21 antigen in lymphocyte transformation by Epstein-Barr virus.
    Boyd AW; Fecondo J
    Immunol Cell Biol; 1988 Apr; 66 ( Pt 2)():159-65. PubMed ID: 2846436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins.
    Rayhel EJ; Dehoff MH; Holers VM
    J Immunol; 1991 Mar; 146(6):2021-6. PubMed ID: 1706386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD21/CD35 in B cell activation.
    Carroll MC
    Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoregulatory role of CD40 in human B cell differentiation.
    Splawski JB; Fu SM; Lipsky PE
    J Immunol; 1993 Feb; 150(4):1276-85. PubMed ID: 7679424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of expression of the antigen identified by FMC7 upon human B-lymphocyte activation: evidence for differences between activation in vivo and in vitro.
    Ferro LM; Zola H
    Immunology; 1990 Mar; 69(3):373-8. PubMed ID: 2138127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.
    Bishop GA; Warren WD; Berton MT
    Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD21 augments antigen presentation in immune individuals.
    Boackle SA; Holers VM; Karp DR
    Eur J Immunol; 1997 Jan; 27(1):122-9. PubMed ID: 9022008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody.
    Boyd AW; Anderson KC; Freedman AS; Fisher DC; Slaughenhoupt B; Schlossman SF; Nadler LM
    J Immunol; 1985 Mar; 134(3):1516-23. PubMed ID: 3871451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens.
    Liu YJ; Zhang J; Lane PJ; Chan EY; MacLennan IC
    Eur J Immunol; 1991 Dec; 21(12):2951-62. PubMed ID: 1748148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targets.
    Ramos OF; Algarra I; Sármay G; Yefenof E; Gergely J; Klein E
    J Immunol; 1989 Jan; 142(1):217-23. PubMed ID: 2521233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor.
    Wheeler K; Pound JD; Gordon J; Jefferis R
    Eur J Immunol; 1993 May; 23(5):1165-8. PubMed ID: 7682959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-cell subsets in blood and lymphoid organs in Macaca fascicularis.
    Vugmeyster Y; Howell K; Bakshi A; Flores C; Hwang O; McKeever K
    Cytometry A; 2004 Sep; 61(1):69-75. PubMed ID: 15351991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.